<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03065530</url>
  </required_header>
  <id_info>
    <org_study_id>2015-SR-203</org_study_id>
    <nct_id>NCT03065530</nct_id>
  </id_info>
  <brief_title>Intravenous Dexmedetomidine for Cesarean Section</brief_title>
  <official_title>Efficacy and Safety of Dexmedetomidine Combined With Butorphanol Tartrate for Postoperative Analgesia and Breastfeeding in Cesarean Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The First Affiliated Hospital with Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The First Affiliated Hospital with Nanjing Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nervous, anxiety, fear and other psychological reactions always appears in parturients during
      cesarean section. This study intends to investigate the effectiveness and safety of
      dexmedetomidine combined with butorphanol tartrate for postoperative analgesia and
      breastfeeding after caesarean section.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 7, 2017</start_date>
  <completion_date type="Actual">October 5, 2017</completion_date>
  <primary_completion_date type="Actual">September 30, 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative pain score</measure>
    <time_frame>6h after cesarean section.</time_frame>
    <description>pain score in the rest and movement with VAS</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative pain score</measure>
    <time_frame>12h after cesarean section.</time_frame>
    <description>pain score in the rest and movement with VAS</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative pain score</measure>
    <time_frame>24h after cesarean section.</time_frame>
    <description>pain score in the rest and movement with VAS</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative pain score</measure>
    <time_frame>48h after cesarean section.</time_frame>
    <description>pain score in the rest and movement with VAS</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Concentration of Dex and butorphanol tartrate</measure>
    <time_frame>6h after cesarean section.</time_frame>
    <description>The concentration of Dex and butorphanol tartrate in breast milk.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Concentration of Dex and butorphanol tartrate</measure>
    <time_frame>12h after cesarean section.</time_frame>
    <description>The concentration of Dex and butorphanol tartrate in breast milk.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Concentration of Dex and butorphanol tartrate</measure>
    <time_frame>24h after cesarean section.</time_frame>
    <description>The concentration of Dex and butorphanol tartrate in breast milk.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Concentration of Dex and butorphanol tartrate</measure>
    <time_frame>48h have enough breast milk.</time_frame>
    <description>The concentration of Dex and butorphanol tartrate in breast milk.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Concentration of Dex and butorphanol tartrate</measure>
    <time_frame>anytime have enough breast milk.</time_frame>
    <description>The concentration of Dex and butorphanol tartrate in breast milk.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ramsay sedation score(RSS)</measure>
    <time_frame>6, 12, 24 and 48h</time_frame>
    <description>Sedation intensity measured with RSS is recorded at the 6, 12 24 and 48 h after cesarean section.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure(systolic and diastolic)</measure>
    <time_frame>0min, 5min, 10min, 30min, 6h, 12h, 24h and 48h.</time_frame>
    <description>blood pressure is recorded at 0 min, 5 min, 10 min, 30 min during surgery and at 6h,12h, 24h and 48h after cesarean section.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>0 min, 5 min, 10 min, 30 min, 6h, 12h, 24h and 48h</time_frame>
    <description>recorded at 0 min, 5 min, 10 min, 30 min during surgery and at 6h,12h, 24h and 48h after cesarean section.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>press times of pump</measure>
    <time_frame>48h</time_frame>
    <description>The total press times during 48h after cesarean section.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>nausea and vomiting</measure>
    <time_frame>48h</time_frame>
    <description>Total times during 48h after cesarean section.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">114</enrollment>
  <condition>Breast Feeding</condition>
  <condition>Analgesia Obstetrical</condition>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The placebo group will pumped in the same volume of saline 0.9% as calculated by parturients' weight in 30 min and receive 1mg butorphanol after delivery.
Postoperative analgesic formula: 3ug/kg/h butorphanol tartrate, diluted with normal saline to 100ml. Background dose: 2ml/h, PCA: 0.5ml, locking time: 15 min.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexmedetomidine 0.03ug/kg/h group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will receive 0.5ug/kg intravenous dexmedetomidine diluted to 4ug/ml in 30 min and 1mg butorphanol tartrate after delivery.
Postoperative analgesic formula: 3ug/kg/h butorphanol tartrate with 0.03ug/kg/h dexmedetomidine, diluted with normal saline to 100ml. Background dose: 2ml/h, PCA: 0.5ml, locking time: 15 min.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexmedetomidine 0.05ug/kg/h group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will receive 0.5ug/kg intravenous dexmedetomidine diluted to 4ug/ml in 30 min and 1mg butorphanol tartrate after delivery.
Postoperative analgesic formula: 3ug/kg/h butorphanol tartrate with 0.05ug/kg/h dexmedetomidine, diluted with normal saline to 100ml. Background dose: 2ml/h, PCA: 0.5ml, locking time: 15 min.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexmedetomidine 0.08ug/kg/h group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will receive 0.5ug/kg intravenous dexmedetomidine diluted to 4ug/ml in 30 min and 1mg butorphanol tartrate after delivery.
Postoperative analgesic formula: 3ug/kg/h butorphanol tartrate with 0.08ug/kg/h dexmedetomidine, diluted with normal saline to 100ml. Background dose: 2ml/h, PCA: 0.5ml, locking time: 15 min.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal Saline</intervention_name>
    <description>Drug: Normal saline control group receive NS after delivery. Drug: butorphanol tartrate PCA: butorphanol tartrate after cesarean section.</description>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine 0.03ug/kg/h</intervention_name>
    <description>Drug: Dexmedetomidine This group receive Dex 0.5ug/kg after delivery. Drug: butorphanol tartrate and Dexmedetomidine. PCA: butorphanol tartrate with 0.03ug/kg/h Dexmedetomidine after cesarean section.</description>
    <arm_group_label>Dexmedetomidine 0.03ug/kg/h group</arm_group_label>
    <other_name>dexmedetomidine Injection</other_name>
    <other_name>Dexmedetomidine Hydrochloride</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine 0.05ug/kg/h</intervention_name>
    <description>Drug: Dexmedetomidine This group receive Dex 0.5ug/kg after delivery. Drug: butorphanol tartrate and Dexmedetomidine. PCA: butorphanol tartrate with 0.05ug/kg/h Dexmedetomidine after cesarean section.</description>
    <arm_group_label>Dexmedetomidine 0.05ug/kg/h group</arm_group_label>
    <other_name>dexmedetomidine Injection</other_name>
    <other_name>Dexmedetomidine Hydrochloride</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine 0.08ug/kg/h</intervention_name>
    <description>Drug: Dexmedetomidine This group receive Dex 0.5ug/kg after delivery. Drug: butorphanol tartrate and Dexmedetomidine. PCA: butorphanol tartrate with 0.08ug/kg/h Dexmedetomidine after cesarean section.</description>
    <arm_group_label>Dexmedetomidine 0.08ug/kg/h group</arm_group_label>
    <other_name>dexmedetomidine Injection</other_name>
    <other_name>Dexmedetomidine Hydrochloride</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Parturients undergoing elective caesarean delivery under epidural anaesthesia

          2. ASA I and II parturients aged 18-42 years, with singleton gestation.

          3. Parturients with verbal and written mandarin

          4. Parturients who want to use PCA intravenous analgesia and can use the pump correctly

          5. written informed consent.

        Exclusion Criteria

          1. Multiple gestation.

          2. A history of allergy to dexmedetomidine or other study drugs

          3. Cardiovascular disease (basic HR&lt;50bpm or SBP&lt;100mmHg)

          4. Opioid drugs abuse.

          5. BMI more than 35 kg/m2

          6. Conditions that preclude spinal anesthesia.

          7. Preeclampsia or epilepsy.

          8. A history of neuromuscular disease.

          9. Epidural anaesthesia was unsuccessful.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The First Affiliated Hospital with Nanjing Medical University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210029</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 18, 2017</study_first_submitted>
  <study_first_submitted_qc>February 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 28, 2017</study_first_posted>
  <last_update_submitted>October 26, 2017</last_update_submitted>
  <last_update_submitted_qc>October 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The First Affiliated Hospital with Nanjing Medical University</investigator_affiliation>
    <investigator_full_name>Shijiang Liu</investigator_full_name>
    <investigator_title>Attending</investigator_title>
  </responsible_party>
  <keyword>Dexmedetomidine</keyword>
  <keyword>Butorphanol tartrate</keyword>
  <keyword>Analgesia</keyword>
  <keyword>Breastfeeding</keyword>
  <keyword>Relative infant dose</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Butorphanol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

